Results 241 to 250 of about 90,738 (349)

Cognition in adults with bottom‐of‐sulcus dysplasia and the consequences of focal resection

open access: yesEpilepsia, EarlyView.
Abstract Objective To determine whether there are cognitive consequences of bottom‐of‐sulcus dysplasia (BOSD) when assessed as adults and whether focal resection of these lesions leads to change in cognition. Methods We studied 42 adults, of whom 39 underwent focal resection targeting the lesion.
Carmen J. Zheng   +4 more
wiley   +1 more source

Sensorimotor Frequency Tagging Is Enhanced by Auditory and Audiovisual but Not Visual, Inputs During a Body-Walking Task. [PDF]

open access: yesPsychophysiology
Matamala-Gomez M   +4 more
europepmc   +1 more source

Insulin‐like growth factor 1 receptor correlates with verbal memory in ILAE type 2 hippocampal sclerosis

open access: yesEpilepsia, EarlyView.
Abstract Objective Long‐term memory deficits are often seen in patients with temporal lobe epilepsy (TLE). Recently, studies showed that patients with hippocampal sclerosis (HS) type 2, which presents with severe neuron loss in CA1 only, performed within the normal range. However, up to 30% of HS type 2 cases have memory deficits.
Henrique Cruz   +10 more
wiley   +1 more source

Dynamic patterns of verbal memory function after an initial decline following temporal lobe resection against epilepsy: Sex‐specific differences in the postoperative course

open access: yesEpilepsia, EarlyView.
Abstract Objective This study was performed to investigate the postoperative dynamics of verbal memory function after temporal lobe resection (TLR) in people with temporal lobe epilepsy (PwTLE), with a specific focus on the course following an initial verbal memory decline and the factors influencing later changes.
Pia Langenberg   +6 more
wiley   +1 more source

Epilepsia partialis continua as the presenting manifestation of Creutzfeldt–Jakob disease: A video‐polygraphic clinical vignette

open access: yes
Epileptic Disorders, EarlyView.
Roberta Cutellè   +8 more
wiley   +1 more source

Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs

open access: yesEpilepsia, EarlyView.
Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy